|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
|
US20030007954A1
(en)
*
|
1999-04-12 |
2003-01-09 |
Gail K. Naughton |
Methods for using a three-dimensional stromal tissue to promote angiogenesis
|
|
WO2001001957A1
(en)
*
|
1999-05-27 |
2001-01-11 |
Biocompatibles Limited |
Local drug delivery
|
|
AU2001237221A1
(en)
|
2000-01-11 |
2001-07-24 |
Roland Bodmeier |
Implants, particles
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8460367B2
(en)
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
DE10044545A1
(de)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
|
DE60131177T2
(de)
|
2000-09-06 |
2008-08-07 |
AP Pharma, Inc., Redwood |
Abbaubare polyacetal-polymere
|
|
PT1328213E
(pt)
|
2000-10-16 |
2005-10-31 |
Conor Medsystems Inc |
Dispositivo medico expansivel para a administracao de um agente benefico
|
|
WO2002038185A2
(en)
*
|
2000-11-13 |
2002-05-16 |
Atrix Laboratories, Inc. |
Injectable sustained release delivery system with loperamide
|
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
|
EP1434571B1
(de)
*
|
2001-10-05 |
2005-05-11 |
SurModics, Inc. |
Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
|
|
US6755869B2
(en)
*
|
2001-11-09 |
2004-06-29 |
Boston Scientific Corporation |
Intragastric prosthesis for the treatment of morbid obesity
|
|
RU2300541C2
(ru)
|
2001-11-15 |
2007-06-10 |
Биоматера Инк. |
Способ получения геля, композиция водного геля и способ изменения его физических характеристик
|
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
|
EP1344538A1
(de)
*
|
2002-03-14 |
2003-09-17 |
Degradable Solutions AG |
Poröses und bioabbaubares Implantatmaterial und Verfahren zu seiner Herstellung
|
|
HUE031167T2
(hu)
*
|
2002-03-20 |
2017-07-28 |
Civitas Therapeutics Inc |
A levodopa pulmonális bejuttatása
|
|
ATE306581T1
(de)
*
|
2002-04-30 |
2005-10-15 |
Cognis Ip Man Gmbh |
Mit mikrokapseln ausgerüstete fasern und textile flächengebilde
|
|
US7432245B2
(en)
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
|
WO2004022000A2
(en)
*
|
2002-09-05 |
2004-03-18 |
Ambrose Catherine G |
Antibiotic microspheres for treatment of infections and osteomyelitis
|
|
US6883194B2
(en)
|
2002-11-08 |
2005-04-26 |
Art Advanced Research And Technology Inc. |
Method and apparatus for positioning a patient on a table for a medical procedure on a breast
|
|
AU2004211991B2
(en)
*
|
2003-02-12 |
2011-03-31 |
Syncera, Inc. |
Random and non-random alkylene oxide polymer alloy compositions
|
|
WO2004081196A2
(en)
*
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
|
AU2004226327A1
(en)
|
2003-03-28 |
2004-10-14 |
Innovational Holdings, Llc |
Implantable medical device with beneficial agent concentration gradient
|
|
DE10314082A1
(de)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradierbares injizierbares Implantat
|
|
CA2521623C
(en)
|
2003-04-11 |
2015-03-17 |
Etex Corporation |
Osteoinductive bone material
|
|
US20040202694A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Vascular Control Systems, Inc. |
Embolic occlusion of uterine arteries
|
|
US20050038501A1
(en)
*
|
2003-08-12 |
2005-02-17 |
Moore James E. |
Dynamic stent
|
|
KR101100045B1
(ko)
*
|
2003-09-23 |
2011-12-29 |
오소콘 인코퍼레이티드 |
흡수성 임플란트 및 지혈 및 골 결손의 치료에서 이를사용하는 방법
|
|
US7955616B2
(en)
*
|
2003-09-23 |
2011-06-07 |
Orthocon, Inc. |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
|
JP2007506505A
(ja)
|
2003-09-23 |
2007-03-22 |
オーソ・セラピューティクス・リミテッド・ライアビリティ・カンパニー |
生体吸収性のパテ様止血性インプラント
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US8673021B2
(en)
|
2003-11-26 |
2014-03-18 |
Depuy Mitek, Llc |
Arthroscopic tissue scaffold delivery device
|
|
KR20050054129A
(ko)
*
|
2003-12-04 |
2005-06-10 |
주식회사 삼양사 |
고분자 미셀을 형성하는 생분해성 분지형 폴리락트산유도체, 및 그의 제조방법 및 용도
|
|
US8263129B2
(en)
|
2003-12-19 |
2012-09-11 |
The University Of North Carolina At Chapel Hill |
Methods for fabricating isolated micro-and nano-structures using soft or imprint lithography
|
|
EP1703895A2
(de)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Zusammensetzung zur cgrp anwendung mit kontrollierter freigabe zur behandlung von kardiovaskulären oder nieren indikationen
|
|
CA2552758A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
|
|
WO2005070444A2
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
|
CN100548271C
(zh)
|
2004-01-20 |
2009-10-14 |
阿勒根公司 |
用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
|
US20050214339A1
(en)
*
|
2004-03-29 |
2005-09-29 |
Yiwen Tang |
Biologically degradable compositions for medical applications
|
|
EP1742648A4
(de)
*
|
2004-04-15 |
2009-03-04 |
Etex Corp |
Calciumphosphatpasten mit verzögerter härtung
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8163030B2
(en)
*
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
|
US20050255045A1
(en)
*
|
2004-05-13 |
2005-11-17 |
Woltering Eugene A |
Surgical marking composition and method
|
|
EP1604693A1
(de)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In-situ hergestelltes Gerüst, dessen Herstellungsverfahren und dessen Verwendung
|
|
CA2573668A1
(en)
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Ophthalmic compositions and methods for treating ophthalmic conditions
|
|
EP2594259A1
(de)
|
2004-08-04 |
2013-05-22 |
Brookwood Pharmaceuticals, Inc. |
Verfahren zur Herstellung von Abgabevorrichtungen und damit erhaltene Vorrichtungen
|
|
ATE424848T1
(de)
*
|
2004-08-12 |
2009-03-15 |
Quest Pharmaceutical Services |
Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
|
|
WO2006026730A2
(en)
*
|
2004-08-30 |
2006-03-09 |
Iken Tissue Therapeutics, Inc. |
Cultured three dimensional tissues and uses thereof
|
|
WO2006026617A2
(en)
*
|
2004-08-30 |
2006-03-09 |
Iken Tissue Therapeutics, Inc. |
Compositions and methods of promoting hair growth
|
|
US20060045902A1
(en)
*
|
2004-09-01 |
2006-03-02 |
Serbousek Jon C |
Polymeric wrap for in vivo delivery of osteoinductive formulations
|
|
US8603528B2
(en)
*
|
2004-09-16 |
2013-12-10 |
Abyrx, Inc. |
Compositions and method for the reduction of post-operative pain
|
|
US20060057184A1
(en)
*
|
2004-09-16 |
2006-03-16 |
Nycz Jeffrey H |
Process to treat avascular necrosis (AVN) with osteoinductive materials
|
|
US20060062811A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Szymczak Christopher E |
Medicinal cooling emulsions
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
WO2006041942A2
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
|
US20080132994A1
(en)
*
|
2004-10-08 |
2008-06-05 |
Robert Burgermeister |
Geometry and non-metallic material for high strength, high flexibility, controlled recoil stent
|
|
WO2006062871A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Pervasis Therapeutics, Inc. |
Materials and methods for minimally-invasive administration of a cell-containing flowable composition
|
|
CN103055350B
(zh)
*
|
2004-12-08 |
2014-12-10 |
夏尔再生医学公司 |
含细胞的可流动组合物的最小侵入性给药的材料和方法
|
|
US20060129226A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Robert Burgermeister |
Material for flexible connectors in high strength, high flexibility, controlled recoil stent
|
|
US20070036843A1
(en)
*
|
2005-01-28 |
2007-02-15 |
Collegium Pharmaceutical, Inc. |
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
|
|
CA2498623A1
(en)
*
|
2005-02-18 |
2006-08-18 |
Qlt Inc. |
Treatment of onychomycosis
|
|
US20100087546A1
(en)
*
|
2005-04-20 |
2010-04-08 |
Biogenic Innovations, Llc |
Use of dimethyl sulfone (msm) to reduce homocysteine levels
|
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
|
US20090087414A1
(en)
*
|
2005-04-21 |
2009-04-02 |
Pervasis Therapeutics, Inc. |
Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
|
|
CA2612188A1
(en)
*
|
2005-06-17 |
2007-01-04 |
Theregen, Inc. |
Methods for treating ischemic tissue
|
|
CN101257861B
(zh)
*
|
2005-06-21 |
2012-12-05 |
渗透治疗有限公司 |
用于增强血管通路的方法和组合物
|
|
KR20080055782A
(ko)
*
|
2005-07-25 |
2008-06-19 |
오소콘 인코퍼레이티드 |
수술 후 통증 경감을 위한 조성물 및 방법
|
|
JP2009502961A
(ja)
|
2005-07-29 |
2009-01-29 |
コンサート ファーマシューティカルズ インコーポレイテッド |
新規な医薬組成物
|
|
JP5399072B2
(ja)
|
2005-09-12 |
2014-01-29 |
アベラ ファーマスーティカルズ インコーポレイテッド |
ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
|
|
EP2324838A1
(de)
|
2005-09-12 |
2011-05-25 |
Abela Pharmaceuticals, Inc. |
Zusammensetzungen mit Dimethyl-Sulfoxid
|
|
US8480797B2
(en)
|
2005-09-12 |
2013-07-09 |
Abela Pharmaceuticals, Inc. |
Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
|
|
US8435224B2
(en)
|
2005-09-12 |
2013-05-07 |
Abela Pharmaceuticals, Inc. |
Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
CA2626082C
(en)
|
2005-10-13 |
2017-04-11 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
|
WO2007067623A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Tyco Healthcare Group Lp |
Biocompatible tissue sealants and adhesives
|
|
US20100204783A1
(en)
*
|
2005-12-06 |
2010-08-12 |
Helen Marie Nugent |
Methods and compositions for enhancing vascular access
|
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
|
EP1960469B1
(de)
|
2005-12-06 |
2016-07-13 |
Covidien LP |
Biologisch absorbierbare verbindungen und diese enthaltende zusammensetzungen
|
|
WO2007067621A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Tyco Healthcare Group Lp |
Biocompatible surgical compositions
|
|
WO2007067625A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Tyco Healthcare Group Lp |
Bioabsorbable surgical composition
|
|
EP1957089A4
(de)
*
|
2005-12-06 |
2012-06-20 |
Tyco Healthcare |
Carbodimid-verneztung von funktionalisierten polyethylen-glykolen
|
|
US8449714B2
(en)
|
2005-12-08 |
2013-05-28 |
Covidien Lp |
Biocompatible surgical compositions
|
|
JP2009518138A
(ja)
*
|
2005-12-08 |
2009-05-07 |
タイコ ヘルスケア グループ リミテッド パートナーシップ |
生体適合性外科用組成物
|
|
CA2629932C
(en)
*
|
2005-12-08 |
2014-07-08 |
Tyco Healthcare Group Lp |
Viscosity-reduced sprayable compositions
|
|
AU2007207618B2
(en)
*
|
2006-01-18 |
2011-03-24 |
Foresee Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions with enhanced stability
|
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US8486135B2
(en)
*
|
2006-06-01 |
2013-07-16 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices fabricated from branched polymers
|
|
US8748419B2
(en)
|
2006-06-16 |
2014-06-10 |
Theracos, Inc. |
Treating obesity with muscarinic receptor M1 antagonists
|
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|
|
US20080003250A1
(en)
*
|
2006-06-21 |
2008-01-03 |
Margulies Barry J |
Novel therapy for herpesvirus infection
|
|
RU2456018C2
(ru)
|
2006-07-11 |
2012-07-20 |
КьюПиЭс, ЭлЭлСи |
Фармацевтические композиции для доставки пептидов с замедленным высвобождением
|
|
US7794495B2
(en)
*
|
2006-07-17 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Controlled degradation of stents
|
|
US8076448B2
(en)
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
JP5372764B2
(ja)
*
|
2006-11-07 |
2013-12-18 |
シャイア リジェネラティブ メディシン， インコーポレイテッド |
血管形成関連疾患の治療および管理のための材料および方法
|
|
US20100004124A1
(en)
*
|
2006-12-05 |
2010-01-07 |
David Taft |
Systems and methods for delivery of materials for agriculture and aquaculture
|
|
US20090263346A1
(en)
*
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
|
CA2670749A1
(en)
*
|
2006-12-05 |
2008-06-12 |
Landec Corporation |
Drug delivery
|
|
US20090246155A1
(en)
*
|
2006-12-05 |
2009-10-01 |
Landec Corporation |
Compositions and methods for personal care
|
|
US8399007B2
(en)
*
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
|
JP2010516680A
(ja)
|
2007-01-19 |
2010-05-20 |
エックスカバリー，インコーポレイテッド |
キナーゼ阻害薬化合物
|
|
DK3660073T3
(da)
|
2007-02-15 |
2023-09-18 |
Tolmar International Ltd |
Poly(lactid-co-glycolid) med lav sprængning
|
|
CN104803957A
(zh)
|
2007-04-02 |
2015-07-29 |
泰拉科斯有限公司 |
苄基化糖苷衍生物及其用法
|
|
BRPI0811319A2
(pt)
|
2007-05-25 |
2015-02-10 |
Tolmar Therapeutics Inc |
Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
|
|
EP2155294B1
(de)
*
|
2007-06-13 |
2012-02-15 |
Pervasis Therapeutics, Inc. |
Verfahren und vorrichtungen zur minimal invasiven abgabe von zellhaltigen fliessfähigen zusammensetzungen
|
|
US8133553B2
(en)
|
2007-06-18 |
2012-03-13 |
Zimmer, Inc. |
Process for forming a ceramic layer
|
|
US8309521B2
(en)
|
2007-06-19 |
2012-11-13 |
Zimmer, Inc. |
Spacer with a coating thereon for use with an implant device
|
|
US8182647B2
(en)
|
2007-07-23 |
2012-05-22 |
Cohera Medical, Inc. |
Hydrophilic biodegradable adhesives
|
|
WO2009026537A1
(en)
|
2007-08-23 |
2009-02-26 |
Theracos, Inc. |
Benzylbenzene derivatives and methods of use
|
|
US8470360B2
(en)
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
|
US20110230973A1
(en)
*
|
2007-10-10 |
2011-09-22 |
Zimmer, Inc. |
Method for bonding a tantalum structure to a cobalt-alloy substrate
|
|
US8608049B2
(en)
|
2007-10-10 |
2013-12-17 |
Zimmer, Inc. |
Method for bonding a tantalum structure to a cobalt-alloy substrate
|
|
US8114883B2
(en)
*
|
2007-12-04 |
2012-02-14 |
Landec Corporation |
Polymer formulations for delivery of bioactive materials
|
|
CA2709712C
(en)
|
2007-12-20 |
2016-05-10 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
US20090187256A1
(en)
*
|
2008-01-21 |
2009-07-23 |
Zimmer, Inc. |
Method for forming an integral porous region in a cast implant
|
|
US20090198286A1
(en)
*
|
2008-02-05 |
2009-08-06 |
Zimmer, Inc. |
Bone fracture fixation system
|
|
US8828354B2
(en)
*
|
2008-03-27 |
2014-09-09 |
Warsaw Orthopedic, Inc. |
Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
|
|
US9314545B2
(en)
*
|
2008-04-15 |
2016-04-19 |
Life Science Enterprises, Inc. |
Minimally invasive treatment of vertebra (MITV) using a calcium phosphate combination bone cement
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
US20090263489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
|
|
US8524267B2
(en)
*
|
2008-04-18 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Dexamethasone formulations in a biodegradable material
|
|
US9132085B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
|
US8722079B2
(en)
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US20090264478A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Sulfasalazine formulations in a biodegradable polymer carrier
|
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
|
US8846068B2
(en)
*
|
2008-04-18 |
2014-09-30 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising a local anesthetic
|
|
US9132119B2
(en)
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
US8557273B2
(en)
*
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US9072727B2
(en)
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
|
US8956641B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
|
US9289409B2
(en)
*
|
2008-04-18 |
2016-03-22 |
Warsaw Orthopedic, Inc. |
Sulindac formulations in a biodegradable material
|
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
|
US8956636B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprosing ketorolac
|
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
JP5757864B2
(ja)
|
2008-05-20 |
2015-08-05 |
ニューロジェシックス， インコーポレイテッド |
水溶性アセトアミノフェン類似体
|
|
KR101677126B1
(ko)
|
2008-05-20 |
2016-11-22 |
노이로제스엑스, 인코포레이티드 |
탄산염 프로드러그 및 그것의 사용 방법
|
|
US9486531B2
(en)
|
2008-06-03 |
2016-11-08 |
Indivior Uk Limited |
Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
|
|
AU2009255675B2
(en)
*
|
2008-06-03 |
2014-10-09 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
CA2728408C
(en)
|
2008-06-19 |
2017-12-05 |
Congxin Liang |
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
|
|
WO2010009243A1
(en)
|
2008-07-15 |
2010-01-21 |
Theracos, Inc. |
Deuterated benzylbenzene derivatives and methods of use
|
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
|
US20100015049A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
|
|
US9492375B2
(en)
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
|
PT2324002T
(pt)
|
2008-08-22 |
2016-11-09 |
Theracos Sub Llc |
Processos para a preparação de inibidores de sglt2
|
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
|
US12171463B2
(en)
|
2008-10-03 |
2024-12-24 |
Femasys Inc. |
Contrast agent generation and injection system for sonographic imaging
|
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
|
US9161903B2
(en)
*
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
|
BRPI0921494A2
(pt)
|
2008-11-03 |
2018-10-30 |
Prad Reasearch And Development Ltd |
método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
|
|
AU2009324894B2
(en)
|
2008-11-25 |
2015-04-09 |
University Of Rochester |
MLK inhibitors and methods of use
|
|
US8815971B2
(en)
|
2008-12-22 |
2014-08-26 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
US8822610B2
(en)
|
2008-12-22 |
2014-09-02 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
US8980317B2
(en)
|
2008-12-23 |
2015-03-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating infections comprising a local anesthetic
|
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
|
US20100226959A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Matrix that prolongs growth factor release
|
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
US9078712B2
(en)
|
2009-04-15 |
2015-07-14 |
Warsaw Orthopedic, Inc. |
Preformed drug-eluting device to be affixed to an anterior spinal plate
|
|
US9414864B2
(en)
|
2009-04-15 |
2016-08-16 |
Warsaw Orthopedic, Inc. |
Anterior spinal plate with preformed drug-eluting device affixed thereto
|
|
US8173750B2
(en)
|
2009-04-23 |
2012-05-08 |
ATRP Solutions, Inc. |
Star macromolecules for personal and home care
|
|
US9783628B2
(en)
|
2009-04-23 |
2017-10-10 |
ATRP Solutions, Inc. |
Dual-mechanism thickening agents for hydraulic fracturing fluids
|
|
WO2014036498A2
(en)
|
2012-08-30 |
2014-03-06 |
ATRP Solutions, Inc. |
Dual mechanism thickening agents for hydraulic fracturing fluids
|
|
WO2010123574A1
(en)
|
2009-04-23 |
2010-10-28 |
Atrp Solutions Inc |
Star macromolecules for personal and home care
|
|
CA2759275C
(en)
|
2009-04-27 |
2017-09-19 |
Premier Dental Products Company |
Microencapsulated compositions and methods for tissue mineralization
|
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
|
US8617583B2
(en)
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US8653029B2
(en)
|
2009-07-30 |
2014-02-18 |
Warsaw Orthopedic, Inc. |
Flowable paste and putty bone void filler
|
|
US8231891B2
(en)
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
|
TWM373127U
(en)
*
|
2009-08-06 |
2010-02-01 |
Liang-Yang Lin |
disassembleable warm-keeping clothing set formed of solar nano-carbon balls composite material
|
|
JP5675820B2
(ja)
*
|
2009-09-22 |
2015-02-25 |
エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ |
様々な生物活性剤担持構成を有するインプラントデバイス
|
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
US9504698B2
(en)
*
|
2009-10-29 |
2016-11-29 |
Warsaw Orthopedic, Inc. |
Flowable composition that sets to a substantially non-flowable state
|
|
AU2010313253B2
(en)
|
2009-10-30 |
2015-02-19 |
Abela Pharmaceuticals, Inc. |
Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
|
|
US8597192B2
(en)
|
2009-10-30 |
2013-12-03 |
Warsaw Orthopedic, Inc. |
Ultrasonic devices and methods to diagnose pain generators
|
|
US8475824B2
(en)
*
|
2010-01-26 |
2013-07-02 |
Warsaw Orthopedic, Inc. |
Resorbable matrix having elongated particles
|
|
US8758791B2
(en)
*
|
2010-01-26 |
2014-06-24 |
Warsaw Orthopedic, Inc. |
Highly compression resistant matrix with porous skeleton
|
|
US9050274B2
(en)
*
|
2010-01-28 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
|
|
US9486500B2
(en)
|
2010-01-28 |
2016-11-08 |
Warsaw Orthopedic, Inc. |
Osteoimplant and methods for making
|
|
US9125902B2
(en)
*
|
2010-01-28 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Methods for treating an intervertebral disc using local analgesics
|
|
CA2794841C
(en)
|
2010-05-20 |
2021-02-23 |
Ecolab Usa Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
|
CA2800176C
(en)
|
2010-05-24 |
2018-08-28 |
University Of Rochester |
Bicyclic heteroaryl kinase inhibitors and methods of use
|
|
SI2394663T1
(sl)
|
2010-05-31 |
2022-02-28 |
Laboratorios Farmaceuticos Rovi, S.A. |
Sestave za injicirane biološko razgradljive vsadke in situ
|
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
|
GB2481017B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
|
GB2513267B
(en)
|
2010-06-08 |
2015-03-18 |
Rb Pharmaceuticals Ltd |
Injectable flowable composition comprising buprenorphine
|
|
WO2011153712A1
(en)
|
2010-06-12 |
2011-12-15 |
Theracos, Inc. |
Crystalline form of benzylbenzene sglt2 inhibitor
|
|
EP3597226A1
(de)
*
|
2010-08-10 |
2020-01-22 |
Lifecell Corporation |
Regenerative gewebegerüste
|
|
US8246571B2
(en)
|
2010-08-24 |
2012-08-21 |
Warsaw Orthopedic, Inc. |
Drug storage and delivery device having a retaining member
|
|
US9126947B2
(en)
|
2010-10-08 |
2015-09-08 |
Xcovery Holding Company Llc |
Substituted pyridazine carboxamide compounds
|
|
US9414930B2
(en)
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
|
US8740982B2
(en)
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
|
US8404268B2
(en)
|
2010-10-26 |
2013-03-26 |
Kyphon Sarl |
Locally targeted anti-fibrotic agents and methods of use
|
|
WO2012075451A2
(en)
|
2010-12-03 |
2012-06-07 |
Warsaw Orthopedic, Inc. |
Clonidine and gaba compounds in a biodegradable polymer carrier
|
|
WO2012075447A2
(en)
|
2010-12-03 |
2012-06-07 |
Warsaw Orthopedic, Inc. |
Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
|
|
US9587064B2
(en)
|
2010-12-08 |
2017-03-07 |
ATRP Solutions, Inc. |
Salt-tolerant star macromolecules
|
|
US9060978B2
(en)
|
2011-01-24 |
2015-06-23 |
Warsaw Orthopedic, Inc. |
Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
|
|
US9717779B2
(en)
|
2011-01-31 |
2017-08-01 |
Warsaw Orthopedic, Inc. |
Implantable matrix having optimum ligand concentrations
|
|
US9592288B2
(en)
|
2011-02-18 |
2017-03-14 |
The Scripps Research Institute |
Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
|
|
EP2677960A4
(de)
|
2011-02-23 |
2016-11-16 |
Boston Scient Scimed Inc |
Beckenimplantat sowie therapiemittelsystem und -verfahren
|
|
US9592243B2
(en)
|
2011-04-25 |
2017-03-14 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for treatment of an injury
|
|
US9511077B2
(en)
|
2011-04-25 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for wound healing
|
|
US8524664B2
(en)
|
2011-06-02 |
2013-09-03 |
Colorado Seminary, Which owns and Operates The Univeristy of Denver |
Methods of treating overproduction of cortisol using ACTH antagonist peptides
|
|
US9205241B2
(en)
|
2011-07-12 |
2015-12-08 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive material
|
|
US9132194B2
(en)
|
2011-07-12 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive sheet containing a drug depot
|
|
US9877929B2
(en)
|
2011-10-13 |
2018-01-30 |
Premier Dental Products Company |
Topical vitamin D and ubiquinol oral supplement compositions
|
|
WO2013123509A1
(en)
*
|
2012-02-17 |
2013-08-22 |
Bacterin International, Inc. |
Adjustable bioactive agent dispersion within a polymeric coating
|
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
|
US8735504B2
(en)
|
2012-05-02 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Methods for preparing polymers having low residual monomer content
|
|
US9724542B2
(en)
|
2012-10-12 |
2017-08-08 |
Premier Dental Products Company |
Remineralizing and desensitizing compositions, treatments and methods of manufacture
|
|
US9877930B2
(en)
|
2012-10-12 |
2018-01-30 |
Premier Dental Products Company |
Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
|
|
CN104884059B
(zh)
|
2012-11-30 |
2018-08-10 |
罗切斯特大学 |
用于hiv/aids治疗的混合谱系激酶抑制剂
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
MX374990B
(es)
|
2013-02-04 |
2025-03-06 |
Pilot Polymer Tech Inc |
Métodos para la elaboración de macromoléculas en forma de estrella tolerantes a las sales que comprende una pluralidad de brazos poliméricos.
|
|
US9663707B2
(en)
*
|
2013-10-23 |
2017-05-30 |
Baker Hughes Incorporated |
Stimulation method using biodegradable zirconium crosslinker
|
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
|
EP4268860A3
(de)
*
|
2014-06-27 |
2024-01-17 |
Boston Scientific Scimed, Inc. |
Zusammensetzungen, vorrichtungen, kits und verfahren zur anbringung von stenthaltigen medizinischen vorrichtungen auf gewebe
|
|
MX385886B
(es)
|
2014-07-03 |
2025-03-18 |
Pilot Polymer Tech Inc |
Macromoleculas estrellas compatibles con tensoactivos.
|
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
US20160106804A1
(en)
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
|
NZ731309A
(en)
|
2014-11-07 |
2022-02-25 |
Indivior Uk Ltd |
Buprenorphine dosing regimens
|
|
KR101891046B1
(ko)
*
|
2014-12-16 |
2018-08-22 |
보스톤 싸이엔티픽 싸이메드 인코포레이티드 |
생분해성 중합체 조성물
|
|
KR102619833B1
(ko)
|
2015-10-09 |
2024-01-03 |
오씨폼 에이피에스 |
3d 인쇄를 위한 공급 원료 및 이의 용도
|
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
|
USD802755S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
|
NZ751284A
(en)
|
2016-10-03 |
2022-09-30 |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Novel jak1 selective inhibitors and uses thereof
|
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
|
KR101942449B1
(ko)
*
|
2016-12-13 |
2019-01-28 |
주식회사 삼양바이오팜 |
생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러
|
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
|
GB2568526A
(en)
*
|
2017-11-20 |
2019-05-22 |
Rebio Tech Oy |
Composition
|
|
WO2019125358A1
(en)
|
2017-12-18 |
2019-06-27 |
Foresee Pharmaceuticals |
Pharmaceutical compositions having a selected release duration
|
|
EP3788147A1
(de)
|
2018-05-04 |
2021-03-10 |
Tollys |
Tlr3-liganden, die sowohl epitheliale als auch myeloische zellen aktivieren
|
|
PE20210047A1
(es)
|
2018-06-12 |
2021-01-08 |
Farm Rovi Lab Sa |
Composicion inyectable
|
|
GB201900258D0
(en)
|
2019-01-08 |
2019-02-27 |
Medincell |
Pharmaceutical composition
|
|
CA3136885A1
(en)
*
|
2019-04-18 |
2020-10-22 |
DePuy Synthes Products, Inc. |
Biocompatible organogel matrices for intraoperative preparation of a drug delivery depot
|
|
GB202010340D0
(en)
*
|
2020-07-06 |
2020-08-19 |
Medincell |
Pharmaceutical composition
|
|
JP7803133B2
(ja)
*
|
2020-10-30 |
2026-01-21 |
東レ株式会社 |
ポリマー組成物および成形体
|
|
FI20215186A1
(en)
*
|
2021-02-19 |
2022-08-20 |
Rebio Tech Oy |
Compositions for ophthalmic treatment
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
US12318387B2
(en)
|
2021-07-16 |
2025-06-03 |
Laboratorios Farmaceuticos Rovi, S.A. |
Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
|
|
US12594236B2
(en)
|
2021-07-16 |
2026-04-07 |
Laboratorios Farmaceuticos Rovi, S.A. |
Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
|
|
EP4385510A4
(de)
|
2021-08-10 |
2025-08-20 |
Betta Pharmaceuticals Co Ltd |
Verwendung von ensartinib oder einem salz davon bei der behandlung von krankheiten mit exon-skipping-mutation von met 14
|
|
TW202313047A
(zh)
|
2021-09-21 |
2023-04-01 |
西班牙商禾霏藥品實驗室有限公司 |
抗精神病可注射儲積型組合物
|
|
EP4527389A4
(de)
|
2022-05-18 |
2026-05-06 |
Farm Rovi Lab Sa |
Injizierbare zusammensetzungen mit verlängerter freisetzung zur verwendung bei der behandlung mit risperidon zusammen mit cyp2d6-enzymhemmern
|
|
WO2025126109A1
(en)
|
2023-12-15 |
2025-06-19 |
Ensem Therapeutics, Inc. |
Anilino-pyrazole derivatives, compositions and methods thereof
|